Morphine promotes apoptosis in Jurkat cells

Journal of Leukocyte Biology

Volumn 66, Issue 4, 1999, Pages 650-658

  Singhal, Pravin C ^a   Kapasi, Aditi A ^b   Reddy, Krishna ^b   Franki, Nicholas ^b   Gibbons, Nora ^b   Ding, Guohua ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Catalase; Heroin addiction; Superoxide dismutase

Indexed keywords

CASPASE 3; CATALASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MORPHINE; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; BASE PAIRING; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0032885219     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.4.650     Document Type: Article

References (39)

1. Luttgens, W. F. (1949) Endocarditis in "main line" opium addicts. Arch. Intern. Med. 83, 653-664.
2. Briggs, J. H., McKerron, C. G., Souhami, R. L., Taylor, D. J. E., Andrews, H. (1967) Severe systemic infections complicating "main line" heroin addiction. Lancet 2, 1227-1231.
3. Brown, S. W., Stimmel, B., Taub, R. N., Koushwa, S., Rosenfeld, R. E. (1974) Immunological dysfunction in heroin addicts. Arch. Intern. Med. 134, 1001-1006.
4. Rojavin, M., Szabo, I., Bussiere, J. L., Rogers, T. J., Adler, M. W., Eisenstein, T. K. (1993) Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 53, 997-1006.
5. Liu, Y., Blaekbourn, D. J., Chuang, L. F., Killam, K. F., Jr., Chuang, R. Y. (1992) Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J. Pharmacol. Exp. Ther. 263, 533-539.
6. Wybran, J., Appelboom, T., Famaey, J. P., Govaerts, A. (1979) Suggestive evidence for receptors for morphine and methionine-enkephalin of normal human blood T lymphocytes. J. Immunol. 123, 1068-1070.
7. Makman, M. H., Dvorkin, B., Stefano, G. B. (1995) Murine macrophage cell lines contain p3-opiate receptors. Eur. J. Pharmacol. 273, R5-R6.
8. Chuang, T. K., Killam, K. F., Chuang, L. F., Kung, H. F., Sheng, W. S., Chao, C. C., Yu, L, Chuang, R. Y. (1995) Mu opioid receptor gene expression in immune cells. Biochem. Biophys. Res. Commun. 209, 563-574.
9. Arora, P. K., Fride, E., Petitto, J., Waggie, K., Skolnick, P. (1990) Morphine-induced immune alterations in vivo. Cell. Immunol. 126, 343-348.
10. Bryant, H. U., Bernton, E. W., Holaday, J. W. (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41, 1731-1738.
11. Bryant, H. U., Yoburn, B. C., Inturrisi, C. E., Bernton, E. W., Holaday, J. W. (1988) Morphine-induced immunosuppression is not related to serum morphine concentrations. Eur. J. Pharmacol. 149, 165-168.
12. Bryant, H. U., Bernton, E. W., Holaday, J. W. (1988) Morphine-pellet induced immunosuppression in mice: temporal relationships. J. Pharmacol. Exp. Ther. 245, 913.
13. Lefkowitz, S. S., Chiang, C. Y. (1975) Effects of certain abused drugs on hemolysin forming cells. Life Sci. 17, 1763-1766.
14. Weber, R. J., Ikejiri, J. B., Rice, K. C., Pert, A., Hagan, A. A. (1987) Opiate receptor mediated regulation of the immune response in vivo. Natl. Inst. Drug Abuse Res. Monogr. 76, 341-348.
15. Shavit, Y., Lewis, J. W., Terman, G. W., Gale, R. P., Liebeskind, J. C. (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell activity. Science 223, 188-190.
16. Weber, R. J., Pert, A. (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245, 188-190.
17. Sei, Y., McIntyre, T., Fride, E., Yoshimoto, K., Skolnick, P., Arora, P. K. (1991) Inhibition of calcium mobilization is an early event in opiate-induced immunosuppression. FASEB J. 5, 2194-2199.
18. Fauci, S. A. (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239, 617-622.
19. Nair, M. P. N., Schwanz, S. A., Polasani, R., Hou, J., Swet, A., Chadha, K. C. (1997) Immunoregulatory effects of morphine on human lymphocytes. Clin. Diagnost. Lab. Immunol. 4, 127-132.
20. + T cells apoptosis. J. Immunol. 158, 2456-2463.
21. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidine thiocyanate phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
22. Yang, E., Korsmeyer, S. J. (1996) Molecular thanaptosis: a discourse on the bcl-2 family and cell death. Blood 88, 386-401.
23. Hengartner, M. O., Horovitz, H. R. (1994) C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell 76, 665-676.
24. Darmon, A. J., Nicholson, D. W., Bleackley, R. C. (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell derived granzyme B. Nature 377, 446-448.
25. Lazebnik, Y. A., Kaufman, S. H., Desnoyers, S., Poirier, G. G., Earnsha, W. C. (1994) Cleavage of ply (ADP-rihose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
26. Mehrishi, J. N., Mills, I. H. (1983) Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27, 240-249.
27. Madden, J. J., Donahoe, R. M., Zwemer-Collins, J., Shafer, D. A., Falek, A. (1987) Binding of naloxone to human T lymphocytes. Biochem. Pharmacol. 36, 4103-4109.
28. Radulescu, R. T., DeCosta, B. R., Jacobson, A. E., Rice, K. E., Blalock, J. E., Carr, D. J. J. (1991) Biochemical and functional characterization of a μu-opioid receptor binding site on cells of the immune system. Prog. Neuroendocrine Immunol. 4, 166-179.
29. Halliwell, B. (1987) Oxidants and human disease: Some new concepts. FASEB J. 1, 358-364.
30. Halliwell, B. (1994) Free radicals, antioxidants, and human disease: Curiosity, cause or consequence? Lancet 344, 721-724.
31. Shearer, G. M., Clerici, M. (1991) Early T helper defects in HIV infection. AIDS 5, 245-253.
32. Tersmette, M., Schuitemaker, H. (1993) Virulent HIV strains? AIDS 7, 1123-1125.
33. Ditzel, H. J., Barbas, S. M., Barbas, C. F., Burton, D. R. (1994) The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. USA 91, 3710-3714.
34. Zinkernagel, R. M., Hengartner, H. (1994) T-cell mediated immunopathology vs. direct cytolysis by virus: Implications for HIV and AIDS. Immunol. Today 15, 262-268.
35. Rossol-Voth, R., Rossol, S., Klein, K., Hess, G., Schutt, H., Schroder, H. C., Meyer zum Buschenfelde, K. H., Muller, W. E. G. (1990) Differential gene expression of IFN-alpha and TNF-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J. Immunol. 144, 970-975.
36. Rossol-Voth R., Rossol, S., Graff, E., Laubenstein, H. P., Muller, W. E. G., Meyer zum Buschenfelde, K. H., Hess, G. (1988) Natural killer cell activity as a prognostic parameter in the progression to AIDS. J. Infect. Dis. 157, 851-860.
37. Dobmeyer, T. S., Findhammer, S., Dobmeyer, J. M., Raffel, B., Hoelzer, D., Helm, E. B., Kabelitz, D., Rossol, R. (1997) Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: Role for lymphocyte loss in HIV infection. Free Rad. Biol. Med. 22, 775-785.
38. Schreck, R., Rieber, P., Baeuerle, P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
39. Yin, D., Mufson, R. A., Wang, R., Shi, Y. (1999) Fas-mediated cell death promoted by opioids. Nature 397, 219.